MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Distribution of Chronotypes in Parkinson’s Disease and its association with Pathological Sleepiness

A. Sarwar (Houston, USA)

Meeting: 2025 International Congress

Keywords: Parkinson’s, Sleep disorders. See also Restless legs syndrome: Pathophysiology

Category: Parkinson's Disease: Non-Motor Symptoms (non-Cognitive/ non-Psychiatric)

Objective: To study the distribution of chronotypes in Veterans with Parkinson’s disease (PD); and its association with pathological sleepiness.

Background: Excessive daytime sleepiness is a common, disabling, non-motor symptom of Parkinson’s disease. Chronotype reflects the periodicity of biological rhythms including the individual’s natural propensity to sleep, hence could be a contributing factor in the expression of pathological sleepiness in patients with PD. This association has not been fully defined.

Method: Chronotypes of one hundred consecutive subjects with Parkinson’s disease were determined using the Horne and Ostberg’s Morningness and Eveningness scale. Subjective sleepiness was assessed using Epworth Sleepiness Scale. The subjects’ depression, cognitive and motor status was assessed using Zung Self Rating Depression Scale (ZDS), Unified Parkinson’s Disease Rating Scale (UPDRS) and Hoehn and Yahr scale (H&Y), respectively.

Results: 60% (60/100) of the subjects were Morning Type (M) [Definitive (M++) = 12, Moderate (M+) =48], 39% (39/100) were Neither Type (N) and 1% (1/100) was Evening Type (E).

Pathological sleepiness (ESS= or > 10): M++ [50% (6/12)], M+ [58% (28/48)], N [77% (30/39)], E [0% (0/1). ESS > 15: was noted in 8%, 14.6%, 23% and 0% in M++, M+, N and E types respectively.

Depression (ZDS = or > 50): M++ [0% (0/12)] M+ [8.3% (4/48)], N [23% (9/39)], E [0% (0/1)].

Intellectual impairment (UPDRS): M++ [None (25%), Mild (75%) mean = 0.75], M+ [None (16.6%) Mild (64.5%) Moderate (14.6%), Severe (4%) mean = 1.06], N [None (20.5%), Mild (53.8%), Moderate (18%), Severe (7.7%); mean=1.13], E [Mild (100%) = 1]

Mean H&Y scores: 2.3, 2.77, 2.77 and 2.5 for M++, M+, N and E types respectively.

Conclusion: The most common chronotype in this cohort of military veterans with Parkinson’s Disease was Morning Type (M) (60%) followed by the Neither type (N) (39%). Evening type (E) (1%) was rare.  Neither type (N) subjects were pathologically the sleepiest followed by the Moderately Morning type.

Pathological sleepiness, intellectual performance, and depression worsened along the chronotype spectrum from the Definitively Morning (M++) to Moderately Morning (M+) to the Neither (N) types. This observation requires further exploration.

To cite this abstract in AMA style:

A. Sarwar. Distribution of Chronotypes in Parkinson’s Disease and its association with Pathological Sleepiness [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/distribution-of-chronotypes-in-parkinsons-disease-and-its-association-with-pathological-sleepiness/. Accessed June 15, 2026.
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/distribution-of-chronotypes-in-parkinsons-disease-and-its-association-with-pathological-sleepiness/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley